New Year's Day drug price hikes hit more than 250 meds

Drugmakers hiked the list prices of more than 250 drugs on New Year's Day in the U.S., according to data from healthcare research firm 3 Axis Advisors.

Reuters exclusively reported Jan. 1 that drugmakers including Pfizer, GlaxoSmithKline and Sanofi raised the list prices on more than 200 drugs. Later in the day, Bristol-Myers Squibb, Gilead Sciences and Biogen increased list prices of about 50 drugs.

The median price increase was about 5 percent, and nearly all of the price increases were below 10 percent.

Many branded drugmakers pledged to keep their U.S. list price hikes below 10 percent a year  following backlash from lawmakers and the public.

More articles on pharmacy:

Amazon's PillPack seeking to win over new insurers in 2020
Roche buys international rights to Sarepta's Duchenne drug for $750M
Former Aegerion sales rep defrauded insurers, stole identities to push cholesterol drug

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers